UNSPSC 51421608: Ulobetasol propionate

This classification denotes a therapeutic glucocorticoid with the molecular formula C25H31ClF2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 91A0K1TY3Z, chemically known as 21-chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate but more generally known as halobetasol propionate, which bears US NIH Compound Identifier 48175. European Medicines Agency schedules Ulobetasol propionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05030MIG.

Most nations, for tariff and trade purposes, schedule ulobetasol propionate under HS 29372200. SMILES: CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)CCL.

UNSPSC 51421608 Ulobetasol propionate is a Commodity code that nominally identifies a potent topical corticosteroid pharmaceutical, but the recent state and local procurement activity tagged under this code does not align with that scope. The single recent opportunity in the record—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—represents opioid-overdose response and harm-reduction equipment, not topical pharmaceutical products. This mismatch suggests either a cataloging error in how the opportunity was tagged or a significant divergence between the code's intended use and current state and local procurement practice.

Seminole County's IFB, posted June 30, 2026, with a response deadline of July 26, 2023, seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The county requires electronic bid submission through its e-Procurement Portal, fixed pricing with all shipping costs included, E-Verify compliance, and drug-free workplace certification. The contract carries a two-year initial term with one-year renewal option and includes a three-month probationary period allowing termination at will. The procurement may draw FEMA funding and subjects vendors to federal environmental compliance requirements. Given the single recent opportunity and its categorical mismatch with the code's pharmaceutical definition, this code shows little relevant recent activity for vendors pursuing topical corticosteroid sales to state and local health agencies.